✦ LIBER ✦

Using recombinant DNA technology for the development of live-attenuated dengue vaccines

✍ Scribed by Hsiang-Chi Lee; Michael Butler; Suh-Chin Wu

Book ID: 113606231
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 457 KB
Volume: 51
Category: Article
ISSN: 0141-0229
DOI: 10.1016/j.enzmictec.2012.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of recombinant DNA technology in

The use of recombinant DNA technology in the development of fish vaccines

✍ C.B. Munn 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 638 KB

DNA encoding infectious-Venezuelan-horse

DNA encoding infectious-Venezuelan-horse-encephalitis virus RNA; used to prepare live attenuated togavirus for use as a recombinant vaccine

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 79 KB

The use of Toxorhynchites splendens for

The use of Toxorhynchites splendens for identification and quantitation of serotypes contained in the tetravalent live attenuated dengue vaccine

✍ Nuananong Jirakanjanakit; Mi Mi Khin; Sutee Yoksan; Natth Bhamarapravati 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 167 KB

An evaluation of dengue type-2 inactivat

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

✍ J. Robert Putnak; Beth-Ann Coller; Gerald Voss; David W. Vaughn; David Clements; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 283 KB

A new series of mycobacterial expression

A new series of mycobacterial expression vectors for the development of live recombinant vaccines

✍ Alain Baulard; Laurent Kremer; Philip Supply; Dominique Vidaud; Jean-Michel Bida 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 547 KB

The development of live attenuated cold-

The development of live attenuated cold-adapted influenza virus vaccine for humans

✍ Hunein F. Maassab; Martin L. Bryant 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

A procedure to attenuate live influenza virus of type A and type B was developed using adaptation of the virus to grow at 25 degrees C (cold adaptation; ca). Through a series of stepwise passages, two stable mutants were obtained and designated as 'Master' strains, one for type A influenza virus (A/